IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Soleus Capital Management, L.P.

Q4 2021 Holdings

Filed 2022-02-14 | 68 holdings | $57.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$23.8K318,2750.0%
Surmodics Inc(SU6)COM868873100$25.7K532,7570.0%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$27.9K478,5960.0%
United Therapeutics Corp del(UTHR)COM91307C102$35.5K164,3000.1%
Bioatla Inc(BCAB)COM09077B104$49.4K2,515,4240.1%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$50.1K3,525,4570.1%
Lantheus Hldgs Inc(LNTH)COM516544103$51.0K1,764,6270.1%
Ishares TR(IWM)PutRUSSELL 2000 ETF464287655$113.1K508,5000.2%
Spdr SER TR(XBI)PutS&P BIOTECH78464A870$144.7K1,292,0000.3%
Beam Therapeutics Inc(BEAM)COM07373V105$227.0K2,8500.4%
Celcuity Inc(CELC)COM15102K100$423.0K32,0730.7%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$624.0K10,2501.1%
Arvinas Inc(ARVN)COM04335A105$904.0K11,0001.6%
Abbvie Inc(ABBV)COM00287Y109$3.7M27,5006.5%
Bioventus Inc(BVS)COM CL A09075A108$6.2M428,39710.9%
Cvrx Inc(CVRX)COM126638105$11.8M962,16520.6%
Angiodynamics Inc(ANGO)COM03475V101$14.2M515,45024.9%
C4 Therapeutics Inc(CCCC)COM STK12529R107$18.1M561,12231.6%
PreviousPage 2 of 2